There is a high burden of both diabetes (DM) and tuberculosis (TB) in
China, and this study aimed to assess feasibility and results of
screening patients with TB for DM within the routine healthcare setting
of six health facilities.
Agreement on how to screen, monitor and record was reached in May 2011
at a stakeholders’ meeting, and training was carried out for staff in
the six facilities in July 2011. Implementation started in September
2011. This is a report on 7 months of activities up to 31 March 2012.
There were 8886 registered patients with TB. They were first asked
whether they had DM. If the answer was no, they were screened with a
random blood glucose (RBG) followed by fasting blood glucose (FBG) in
those with RBG ≤ 6.1 mm (one facility) or with an initial FBG (five
facilities). Those with FBG ≥7.0 mm were referred to DM clinics for
diagnostic confirmation with a second FBG. Altogether, 1090 (12.4%)
patients with DM were identified, of whom 863 (9.7%) had a known
diagnosis of DM. Of 8023 patients who needed screening for DM, 7947
(99%) were screened. This resulted in a new diagnosis of DM in 227
patients (2.9% of screened patients), and of these, 226 were enrolled to
DM care. In addition, 575 (7.8%) persons had impaired fasting glucose
(FBG 6.1 to
This pilot project shows that it is feasible to screen patients with TB
for DM in the routine setting, resulting in a high yield of patients
with known and newly diagnosed disease. Free blood tests for glucose
measurement and integration of TB and DM services may improve the
diagnosis and management of dually affected patients.
Li, L.; Lin, Y.; Mi, F.; Tan, S.; Liang, B.; Guo, C.; Shi, L.; Liu, L.; Gong, F.; Li, Y.; Chi, J.; Zachariah, R.; Kapur, A.; Lonnroth, K.; Harries, AD. Screening of patients with tuberculosis for diabetes mellitus in China. Tropical Medicine and International Health (2012) 17 (10) 1294-1301. [DOI: 10.1111/j.1365-3156.2012.03068.x]
Screening patients with tuberculosis for diabetes mellitus in China.